Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

South Korea flag South Korea · Delayed Price · Currency is KRW
29,800
-200 (-0.67%)
Last updated: Dec 10, 2025, 10:14 AM KST
16.18%
Market Cap176.40B
Revenue (ttm)209.00B
Net Income (ttm)31.56B
Shares Out5.88M
EPS (ttm)5,366.74
PE Ratio5.59
Forward PE5.79
Dividend900.00 (3.01%)
Ex-Dividend DateDec 29, 2025
Volume1,977
Average Volume15,694
Open30,000
Previous Close30,000
Day's Range29,650 - 30,150
52-Week Range24,750 - 33,950
Beta0.20
RSI48.18
Earnings DateMar 18, 2026

About Daihan Pharmaceutical

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1945
Employees 553
Stock Exchange KOSDAQ
Ticker Symbol 023910
Full Company Profile

Financial Performance

In 2024, Daihan Pharmaceutical's revenue was 204.19 billion, an increase of 4.23% compared to the previous year's 195.91 billion. Earnings were 33.76 billion, an increase of 18.76%.

Financial Statements

News

There is no news available yet.